A detailed history of Truvestments Capital LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Truvestments Capital LLC holds 68 shares of PRTA stock, worth $675. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68
Previous 68 -0.0%
Holding current value
$675
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$16.73 - $24.79 $1,137 - $1,685
68 New
68 $1,000
Q1 2023

May 12, 2023

BUY
$46.97 - $58.27 $5,072 - $6,293
108 New
108 $5,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $466M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.